An Overview of the Recent Advances in Antimicrobial Resistance.

Manuela Oliveira, Wilson Antunes, Salete Mota, Áurea Madureira-Carvalho, Ricardo Jorge Dinis-Oliveira, Diana Dias da Silva
Author Information
  1. Manuela Oliveira: Associate Laboratory i4HB-Institute for Health and Bioeconomy, University Institute of Health Sciences-CESPU, Avenida Central de Gandra 1317, 4585-116 Gandra, Portugal. ORCID
  2. Wilson Antunes: Instituto Universitário Militar, CINAMIL, Unidade Militar Laboratorial de Defesa Biológica e Química, Avenida Doutor Alfredo Bensaúde, 4 piso, do LNM, 1849-012 Lisbon, Portugal.
  3. Salete Mota: ULSEDV-Unidade Local De Saúde De Entre Douro Vouga, Unidade de Santa Maria da Feira e Hospital S. Sebastião, Rua Dr. Cândido Pinho, 4520-211 Santa Maria da Feira, Portugal.
  4. Áurea Madureira-Carvalho: Associate Laboratory i4HB-Institute for Health and Bioeconomy, University Institute of Health Sciences-CESPU, Avenida Central de Gandra 1317, 4585-116 Gandra, Portugal. ORCID
  5. Ricardo Jorge Dinis-Oliveira: Associate Laboratory i4HB-Institute for Health and Bioeconomy, University Institute of Health Sciences-CESPU, Avenida Central de Gandra 1317, 4585-116 Gandra, Portugal. ORCID
  6. Diana Dias da Silva: Associate Laboratory i4HB-Institute for Health and Bioeconomy, University Institute of Health Sciences-CESPU, Avenida Central de Gandra 1317, 4585-116 Gandra, Portugal. ORCID

Abstract

Antimicrobial resistance (AMR), frequently considered a major global public health threat, requires a comprehensive understanding of its emergence, mechanisms, advances, and implications. AMR's epidemiological landscape is characterized by its widespread prevalence and constantly evolving patterns, with multidrug-resistant organisms (MDROs) creating new challenges every day. The most common mechanisms underlying AMR (i.e., genetic mutations, horizontal gene transfer, and selective pressure) contribute to the emergence and dissemination of new resistant strains. Therefore, mitigation strategies (e.g., antibiotic stewardship programs-ASPs-and infection prevention and control strategies-IPCs) emphasize the importance of responsible antimicrobial use and surveillance. A One Health approach (i.e., the interconnectedness of human, animal, and environmental health) highlights the necessity for interdisciplinary collaboration and holistic strategies in combating AMR. Advancements in novel therapeutics (e.g., alternative antimicrobial agents and vaccines) offer promising avenues in addressing AMR challenges. Policy interventions at the international and national levels also promote ASPs aiming to regulate antimicrobial use. Despite all of the observed progress, AMR remains a pressing concern, demanding sustained efforts to address emerging threats and promote antimicrobial sustainability. Future research must prioritize innovative approaches and address the complex socioecological dynamics underlying AMR. This manuscript is a comprehensive resource for researchers, policymakers, and healthcare professionals seeking to navigate the complex AMR landscape and develop effective strategies for its mitigation.

Keywords

References

  1. Pharmaceutics. 2018 Jan 14;10(1): [PMID: 29342903]
  2. Med Microbiol Immunol. 2020 Apr;209(2):95-108 [PMID: 31802195]
  3. Antibiotics (Basel). 2022 Mar 06;11(3): [PMID: 35326811]
  4. Front Public Health. 2021 May 31;9:673504 [PMID: 34136458]
  5. Am J Infect Control. 2022 Aug;50(8):898-905 [PMID: 35908829]
  6. Antibiotics (Basel). 2020 Oct 13;9(10): [PMID: 33066005]
  7. Mycopathologia. 2020 Jun;185(3):415-424 [PMID: 32277380]
  8. One Health. 2022 Jun 28;15:100412 [PMID: 36277092]
  9. BMJ Glob Health. 2021 May;6(5): [PMID: 33975888]
  10. Antibiotics (Basel). 2023 Aug 24;12(9): [PMID: 37760659]
  11. Int J Environ Res Public Health. 2021 Sep 18;18(18): [PMID: 34574760]
  12. Trends Pharmacol Sci. 2017 Jun;38(6):506-511 [PMID: 28473165]
  13. Br Med Bull. 2018 Mar 1;125(1):25-41 [PMID: 29190327]
  14. N Engl J Med. 2020 Apr 2;382(14):1309-1319 [PMID: 32242356]
  15. Clin Infect Dis. 2006 Jan 15;42 Suppl 2:S82-9 [PMID: 16355321]
  16. Vet Anim Sci. 2022 Mar 30;16:100249 [PMID: 35479515]
  17. Glob Health Action. 2018;11(1):1483637 [PMID: 29921172]
  18. Antibiotics (Basel). 2015 Oct 30;4(4):467-79 [PMID: 27025636]
  19. Biomed Res Int. 2016;2016:2475067 [PMID: 27274985]
  20. BMJ Open. 2019 May 19;9(5):e027683 [PMID: 31110101]
  21. Antibiotics (Basel). 2016 Nov 02;5(4): [PMID: 27827853]
  22. Life (Basel). 2021 Jun 07;11(6): [PMID: 34200116]
  23. Front Mol Biosci. 2021 Mar 18;8:648468 [PMID: 33816561]
  24. Infect Control Hosp Epidemiol. 2017 May;38(5):580-594 [PMID: 28294079]
  25. Hepatology. 2015 Feb;61(2):712-21 [PMID: 25048716]
  26. Antibiotics (Basel). 2022 May 11;11(5): [PMID: 35625288]
  27. Parasitol Today. 1988 Jan;4(1):4-10 [PMID: 15462989]
  28. Lancet Reg Health Am. 2023 Apr 06;21:100484 [PMID: 37096191]
  29. Antibiotics (Basel). 2018 Jul 27;7(3): [PMID: 30060506]
  30. Environ Int. 2018 Aug;117:132-138 [PMID: 29747082]
  31. Int J Mol Sci. 2020 Feb 18;21(4): [PMID: 32085478]
  32. Front Microbiol. 2016 Nov 01;7:1728 [PMID: 27847505]
  33. Science. 2020 May 1;368(6490): [PMID: 32355003]
  34. Int Microbiol. 2023 Jan;26(1):1-9 [PMID: 36224500]
  35. Microorganisms. 2022 Aug 08;10(8): [PMID: 36014017]
  36. Antimicrob Resist Infect Control. 2024 Feb 8;13(1):16 [PMID: 38331974]
  37. MMWR Morb Mortal Wkly Rep. 2015 Aug 7;64(30):826-31 [PMID: 26247436]
  38. Expert Rev Anti Infect Ther. 2019 Aug;17(8):621-634 [PMID: 31282277]
  39. Microbiol Res. 2021 Nov;252:126856 [PMID: 34454311]
  40. Antibiotics (Basel). 2022 May 16;11(5): [PMID: 35625313]
  41. Intern Med J. 2017 Dec;47(12):1341-1351 [PMID: 29224205]
  42. Health Aff (Millwood). 2019 Jul;38(7):1163-1172 [PMID: 31260344]
  43. Antimicrob Agents Chemother. 2015 Jan;59(1):450-60 [PMID: 25385095]
  44. PLoS One. 2023 May 8;18(5):e0285170 [PMID: 37155660]
  45. J Infect Public Health. 2022 Feb;15(2):172-181 [PMID: 34972026]
  46. Antibiotics (Basel). 2023 Jul 01;12(7): [PMID: 37508237]
  47. Trends Genet. 2020 Dec;36(12):915-925 [PMID: 33012528]
  48. PLoS One. 2024 Feb 5;19(2):e0297921 [PMID: 38315668]
  49. Microb Drug Resist. 2016 Jul;22(5):412-31 [PMID: 26866778]
  50. Zoonoses Public Health. 2015 Apr;62 Suppl 1:1-2 [PMID: 25903490]
  51. Euro Surveill. 2018 Oct;23(42): [PMID: 30352643]
  52. Biomedicines. 2023 Mar 31;11(4): [PMID: 37189681]
  53. Curr Opin Infect Dis. 2016 Dec;29(6):654-662 [PMID: 27306564]
  54. Cell Rep. 2019 Nov 26;29(9):2917-2928.e5 [PMID: 31775055]
  55. Infect Dis Clin North Am. 2021 Sep;35(3):771-787 [PMID: 34362543]
  56. Curr Opin Microbiol. 2021 Dec;64:133-138 [PMID: 34710742]
  57. Open Forum Infect Dis. 2020 Mar 13;7(7):ofaa083 [PMID: 32667365]
  58. Microorganisms. 2024 Apr 11;12(4): [PMID: 38674716]
  59. Antimicrob Agents Chemother. 2000 Jun;44(6):1524-9 [PMID: 10817703]
  60. Virus Evol. 2016 Jun 10;2(1):vew014 [PMID: 28694997]
  61. Food Sci Biotechnol. 2022 Sep 1;31(12):1481-1499 [PMID: 36065433]
  62. Euro Surveill. 2017 Nov;22(46): [PMID: 29162208]
  63. Infection. 2019 Feb;47(1):7-11 [PMID: 30178076]
  64. BMC Public Health. 2021 Aug 6;21(1):1517 [PMID: 34362321]
  65. Front Microbiol. 2020 Oct 22;11:585175 [PMID: 33193230]
  66. Clin Microbiol Infect. 2023 Apr;29(4):429-433 [PMID: 35595126]
  67. Glob Health Action. 2019;12(1):1599560 [PMID: 31294679]
  68. N Z Vet J. 2017 Mar;65(2):57-59 [PMID: 27943681]
  69. Int J Antimicrob Agents. 2023 Jul;62(1):106816 [PMID: 37061101]
  70. Environ Toxicol Pharmacol. 2022 Nov;96:103995 [PMID: 36210048]
  71. Antimicrob Resist Infect Control. 2016 Dec 12;5:56 [PMID: 27999665]
  72. Healthcare (Basel). 2023 Jul 05;11(13): [PMID: 37444780]
  73. Science. 2020 Feb 7;367(6478):630-632 [PMID: 32029617]
  74. Am J Infect Control. 2023 Nov;51(11S):A3-A12 [PMID: 37890951]
  75. Trends Microbiol. 2019 Apr;27(4):323-338 [PMID: 30683453]
  76. Global Health. 2023 Apr 20;19(1):27 [PMID: 37081463]
  77. Infect Dis Now. 2024 Jun;54(4):104895 [PMID: 38548016]
  78. PLoS One. 2017 Dec 21;12(12):e0189621 [PMID: 29267306]
  79. Nanoscale. 2022 Mar 17;14(11):4018-4041 [PMID: 35234774]
  80. Microorganisms. 2023 Jul 27;11(8): [PMID: 37630472]
  81. Microb Drug Resist. 2017 Mar;23(2):147-156 [PMID: 27214143]
  82. JAMA. 2014 Jan 22-29;311(4):347-8 [PMID: 24449297]
  83. Med Sci (Basel). 2021 Feb 21;9(1): [PMID: 33669981]
  84. Int J Antimicrob Agents. 2015 Oct;46(4):359-61 [PMID: 26242553]
  85. Int J Infect Dis. 2020 Jul;96:621-629 [PMID: 32505875]
  86. Antibiotics (Basel). 2023 Mar 22;12(3): [PMID: 36978495]
  87. BMJ Glob Health. 2016 Dec 30;1(4):e000125 [PMID: 28588979]
  88. Am J Infect Control. 2020 Apr;48(4):433-442 [PMID: 31444097]
  89. Curr Opin Microbiol. 2012 Oct;15(5):561-9 [PMID: 22890188]
  90. Front Microbiol. 2017 Jun 20;8:1108 [PMID: 28676794]
  91. Sci Adv. 2021 Oct 22;7(43):eabj5056 [PMID: 34678056]
  92. Ambio. 2023 May;52(5):941-951 [PMID: 36723847]
  93. Front Immunol. 2021 Feb 18;11:622614 [PMID: 33679711]
  94. Nature. 2022 Aug;608(7922):390-396 [PMID: 35922513]
  95. Proc Natl Acad Sci U S A. 2008 Apr 1;105(13):5022-7 [PMID: 18367671]
  96. Microorganisms. 2023 Apr 17;11(4): [PMID: 37110473]
  97. Microbiol Res. 2022 Nov;264:127155 [PMID: 35969943]
  98. Global Health. 2022 Oct 17;18(1):85 [PMID: 36253789]
  99. Antiviral Res. 2014 Feb;102:70-86 [PMID: 24345729]
  100. Antibiotics (Basel). 2020 Apr 20;9(4): [PMID: 32326058]
  101. Infect Prev Pract. 2020 Jul 19;2(3):100077 [PMID: 34368717]
  102. Front Chem. 2022 Jan 10;9:795433 [PMID: 35083194]
  103. Angew Chem Int Ed Engl. 2024 Feb 26;63(9):e202314728 [PMID: 38161189]
  104. Antibiotics (Basel). 2020 Nov 07;9(11): [PMID: 33171743]
  105. Br J Biomed Sci. 2023 Jun 28;80:11387 [PMID: 37448857]
  106. Emerg Infect Dis. 2023 Mar;29(3):1-9 [PMID: 36823026]
  107. Microorganisms. 2023 Nov 17;11(11): [PMID: 38004808]
  108. Glob Health Epidemiol Genom. 2017 May 10;2:e4 [PMID: 29276617]
  109. Antibiotics (Basel). 2021 May 13;10(5): [PMID: 34068272]
  110. J Hazard Mater. 2021 Jun 5;411:125148 [PMID: 33486226]
  111. Antimicrob Resist Infect Control. 2018 Nov 15;7:136 [PMID: 30473786]
  112. J Infect Dis. 2011 Dec 15;204(12):1980-8 [PMID: 22021623]
  113. Sci Total Environ. 2020 Oct 15;739:140356 [PMID: 32758969]
  114. Curr Opin Microbiol. 2018 Oct;45:70-76 [PMID: 29547801]
  115. Infect Dis Clin North Am. 2021 Jun;35(2):279-311 [PMID: 34016279]
  116. Molecules. 2022 Jul 18;27(14): [PMID: 35889455]
  117. Crit Care. 2016 Jun 22;20(1):136 [PMID: 27329228]
  118. Med Humanit. 2022 Dec;48(4):e16 [PMID: 35321873]
  119. Antimicrob Resist Infect Control. 2018 Apr 24;7:55 [PMID: 29719718]
  120. Curr Opin Infect Dis. 2019 Dec;32(6):553-558 [PMID: 31567566]
  121. Infect Drug Resist. 2018 Apr 11;11:523-530 [PMID: 29695921]
  122. Clin Ther. 2020 Sep;42(9):1659-1680 [PMID: 32883528]
  123. Glob Chall. 2021 Jun 10;5(10):2100017 [PMID: 34631149]
  124. Infect Dis Clin North Am. 2016 Jun;30(2):377-390 [PMID: 27208764]
  125. Biochem Pharmacol. 2024 Aug;226:116400 [PMID: 38945275]
  126. Vaccines (Basel). 2023 Feb 01;11(2): [PMID: 36851210]
  127. Clin Microbiol Rev. 2020 May 13;33(3): [PMID: 32404434]
  128. Environ Sci Technol. 2022 Jul 5;56(13):9149-9160 [PMID: 35732277]
  129. Br J Clin Pharmacol. 2015 Feb;79(2):173-81 [PMID: 24803175]
  130. Front Cell Infect Microbiol. 2022 Nov 23;12:952491 [PMID: 36506027]
  131. Future Microbiol. 2020 Jan;15:9-20 [PMID: 32043371]
  132. Commun Biol. 2021 Sep 9;4(1):1050 [PMID: 34504303]
  133. Life Sci. 2022 Apr 15;295:120391 [PMID: 35149116]
  134. Fam Pract. 2020 Mar 25;37(2):276-282 [PMID: 31690948]
  135. MMWR Morb Mortal Wkly Rep. 2020 Dec 04;69(48):1827-1831 [PMID: 33270611]
  136. Microbiologyopen. 2020 Sep;9(9):e1035 [PMID: 32710495]
  137. Nat Rev Dis Primers. 2018 May 31;4:18033 [PMID: 29849094]
  138. Genes (Basel). 2020 Oct 22;11(11): [PMID: 33105635]
  139. Microorganisms. 2022 Aug 26;10(9): [PMID: 36144323]
  140. Antimicrob Resist Infect Control. 2018 Aug 9;7:98 [PMID: 30116525]
  141. Int J Antimicrob Agents. 2023 Dec;62(6):107014 [PMID: 37866472]
  142. ACS Infect Dis. 2018 Mar 9;4(3):291-300 [PMID: 29397687]
  143. mBio. 2022 Jun 28;13(3):e0033622 [PMID: 35548953]
  144. Infect Dis Clin North Am. 2021 Dec;35(4):931-952 [PMID: 34752226]
  145. Crit Rev Microbiol. 2016;42(2):276-92 [PMID: 25159043]
  146. Rev Sci Tech. 2012 Apr;31(1):23-31 [PMID: 22849265]
  147. Surg Infect (Larchmt). 2015 Dec;16(6):716-20 [PMID: 26186101]
  148. Nat Rev Microbiol. 2019 Oct;17(10):607-620 [PMID: 31444481]
  149. BMC Med. 2018 Jun 4;16(1):78 [PMID: 29860943]
  150. Pathogens. 2023 Aug 23;12(9): [PMID: 37764882]
  151. J Agric Food Chem. 2020 Oct 28;68(43):11908-11919 [PMID: 32970417]
  152. CMAJ. 1998 Nov 3;159(9):1129-36 [PMID: 9835883]
  153. Philos Trans R Soc Lond B Biol Sci. 2014 May 12;369(1645):20130430 [PMID: 24821916]
  154. Infect Drug Resist. 2020 May 05;13:1287-1294 [PMID: 32440165]
  155. JAC Antimicrob Resist. 2022 Mar 18;4(2):dlac017 [PMID: 35310573]
  156. Ann N Y Acad Sci. 2020 Jan;1459(1):86-105 [PMID: 31792983]
  157. Diagnostics (Basel). 2017 Nov 29;7(4): [PMID: 29186013]
  158. BMC Infect Dis. 2023 Mar 7;23(1):132 [PMID: 36882700]
  159. Proc Natl Acad Sci U S A. 2018 Dec 18;115(51):12887-12895 [PMID: 30559181]
  160. J Glob Antimicrob Resist. 2018 Jun;13:226-230 [PMID: 29409949]
  161. Curr Opin Infect Dis. 2021 Oct 1;34(5):423-431 [PMID: 34267046]
  162. Antibiotics (Basel). 2021 Jul 19;10(7): [PMID: 34356799]
  163. Antimicrob Resist Infect Control. 2021 Mar 31;10(1):63 [PMID: 33789754]
  164. Antibiotics (Basel). 2022 Jan 05;11(1): [PMID: 35052940]
  165. Bull World Health Organ. 2015 Jul 1;93(7):439 [PMID: 26170498]
  166. Annu Rev Med. 2020 Jan 27;71:137-148 [PMID: 31986084]
  167. J Hosp Infect. 2024 Aug;150:61-71 [PMID: 38830541]
  168. BMC Public Health. 2017 Nov 23;17(1):896 [PMID: 29169340]
  169. J Fungi (Basel). 2022 Oct 26;8(11): [PMID: 36354893]
  170. Aust J Gen Pract. 2022 Jan-Feb;51(1-2):21-24 [PMID: 35098268]
  171. J Fungi (Basel). 2020 Aug 18;6(3): [PMID: 32824785]
  172. J Hosp Infect. 2024 May;147:25-31 [PMID: 38447803]
  173. Antibiotics (Basel). 2022 Feb 04;11(2): [PMID: 35203804]
  174. J Antimicrob Chemother. 2020 Dec 6;75(Suppl 2):ii33-ii41 [PMID: 33280047]
  175. Antimicrob Agents Chemother. 1993 Jan;37(1):126-7 [PMID: 8381633]
  176. Crit Rev Biochem Mol Biol. 2018 Feb;53(1):29-48 [PMID: 29108429]
  177. FEMS Microbiol Rev. 2018 Jan 1;42(1): [PMID: 29069382]
  178. EMBO Rep. 2019 Feb;20(2): [PMID: 30602585]
  179. Antibiotics (Basel). 2020 Aug 01;9(8): [PMID: 32752276]
  180. Evid Based Nurs. 2023 Jul 27;: [PMID: 37500506]
  181. Am J Lifestyle Med. 2017 Apr 04;13(4):376-383 [PMID: 31285722]
  182. Infect Drug Resist. 2017 Aug 30;10:261-273 [PMID: 28919790]
  183. Viruses. 2021 Nov 23;13(12): [PMID: 34960617]
  184. Philos Trans R Soc Lond B Biol Sci. 2015 Jun 5;370(1670):20140086 [PMID: 25918443]
  185. Front Microbiol. 2019 May 22;10:1134 [PMID: 31191478]
  186. Nihon Rinsho. 1997 May;55(5):1185-90 [PMID: 9155173]
  187. Curr Opin Pharmacol. 2014 Oct;18:56-60 [PMID: 25254623]
  188. Med J Armed Forces India. 2015 Apr;71(2):178-81 [PMID: 25859082]
  189. Curr Opin Microbiol. 2019 Oct;51:39-45 [PMID: 31077935]
  190. ACS Infect Dis. 2020 Jun 12;6(6):1317-1322 [PMID: 32202756]
  191. Biomed Res Int. 2015;2015:214021 [PMID: 25945327]
  192. Viruses. 2023 Jun 28;15(7): [PMID: 37515150]
  193. Front Cell Infect Microbiol. 2023 Jun 14;13:1199646 [PMID: 37389209]
  194. Expert Rev Anti Infect Ther. 2016 Dec;14(12):1215-1223 [PMID: 27548801]
  195. Eur J Intern Med. 2022 May;99:7-12 [PMID: 35074246]
  196. Front Cell Infect Microbiol. 2021 Nov 25;11:771510 [PMID: 34900756]
  197. Glob Health Action. 2019 Dec 13;12(sup1):1855831 [PMID: 33357144]
  198. Annu Rev Microbiol. 2020 Sep 8;74:431-454 [PMID: 32905757]
  199. Antimicrob Resist Infect Control. 2017 Nov 15;6:113 [PMID: 29163939]
  200. Curr Opin Microbiol. 2020 Oct;57:56-61 [PMID: 32777653]
  201. Global Health. 2020 Nov 11;16(1):109 [PMID: 33176810]
  202. Future Med Chem. 2015;7(17):2301-4 [PMID: 26619140]
  203. Front Cell Infect Microbiol. 2024 Feb 02;14:1289134 [PMID: 38384304]
  204. Curr Opin Microbiol. 2020 Oct;57:95-101 [PMID: 33147565]
  205. Appl Microbiol Biotechnol. 2022 Oct;106(19-20):6427-6440 [PMID: 36121484]
  206. Curr Opin Microbiol. 2019 Oct;51:72-80 [PMID: 31733401]
  207. Vet Sci. 2023 Apr 28;10(5): [PMID: 37235402]
  208. Antibiotics (Basel). 2017 Oct 31;6(4): [PMID: 29088074]
  209. Trop Med Infect Dis. 2021 Jan 16;6(1): [PMID: 33467065]
  210. Front Microbiol. 2021 Oct 25;12:718774 [PMID: 34759896]
  211. Gut Microbes. 2021 Jan-Dec;13(1):1-13 [PMID: 33870869]
  212. Gastrointest Endosc Clin N Am. 2020 Oct;30(4):619-635 [PMID: 32891221]
  213. PLoS One. 2018 May 31;13(5):e0198103 [PMID: 29851962]
  214. Expert Rev Anti Infect Ther. 2016 Nov;14(11):1065-1075 [PMID: 27599796]
  215. PLoS Pathog. 2019 Apr 8;15(4):e1007638 [PMID: 30958866]
  216. Antibiotics (Basel). 2021 Dec 11;10(12): [PMID: 34943732]
  217. Wellcome Open Res. 2017 Sep 26;2:92 [PMID: 29062918]
  218. Med Mycol J. 2018;59(2):E31-E40 [PMID: 29848909]
  219. J Glob Antimicrob Resist. 2020 Jun;21:255-261 [PMID: 31505299]
  220. Microorganisms. 2023 Mar 26;11(4): [PMID: 37110267]
  221. Cold Spring Harb Perspect Med. 2016 Sep 01;6(9): [PMID: 27481773]
  222. Drug Discov Today. 2021 Sep;26(9):2084-2089 [PMID: 33610472]
  223. Clin Infect Dis. 2003 Jun 1;36(11):1433-7 [PMID: 12766839]
  224. Curr Med Chem. 2017;24(38):4303-4314 [PMID: 28814242]
  225. Clin Microbiol Rev. 2009 Apr;22(2):291-321, Table of Contents [PMID: 19366916]
  226. Nat Rev Microbiol. 2022 Apr;20(4):206-218 [PMID: 34773098]
  227. Front Microbiol. 2017 Nov 02;8:2124 [PMID: 29163414]
  228. Infect Drug Resist. 2021 Dec 07;14:5235-5252 [PMID: 34908856]
  229. J Antimicrob Chemother. 2017 Nov 1;72(11):2963-2972 [PMID: 28961709]
  230. Ig Sanita Pubbl. 2019 Nov-Dec;75(6):429-450 [PMID: 32242168]
  231. J Glob Antimicrob Resist. 2021 Mar;24:285-295 [PMID: 33484895]
  232. J Glob Antimicrob Resist. 2021 Jun;25:40-47 [PMID: 33662643]
  233. Front Public Health. 2020 Aug 27;8:454 [PMID: 32974264]
  234. Nat Commun. 2019 Mar 8;10(1):1124 [PMID: 30850636]
  235. Curr Opin Biotechnol. 2021 Apr;68:1-7 [PMID: 33007632]
  236. Curr Infect Dis Rep. 2022;24(5):63-75 [PMID: 35535263]
  237. JAC Antimicrob Resist. 2022 Aug 02;4(4):dlac083 [PMID: 35928475]
  238. Bull World Health Organ. 2020 Mar 1;98(3):151 [PMID: 32132745]
  239. Fungal Genet Biol. 2019 Nov;132:103252 [PMID: 31302289]
  240. Curr Opin Microbiol. 2022 Oct;69:102193 [PMID: 36007459]
  241. Euro Surveill. 2018 Oct;23(42): [PMID: 30352641]
  242. ACS Infect Dis. 2021 Oct 8;7(10):2777-2786 [PMID: 34472830]
  243. Sci Total Environ. 2024 Feb 20;912:168908 [PMID: 38013098]
  244. BMJ Glob Health. 2024 Apr 3;9(4): [PMID: 38569658]
  245. Antimicrob Agents Chemother. 2015 Sep;59(9):5316-23 [PMID: 26100695]
  246. Biomedicines. 2024 Apr 20;12(4): [PMID: 38672269]
  247. Science. 2020 Jan 3;367(6473):51-59 [PMID: 31896710]
  248. Expert Rev Anti Infect Ther. 2008 Oct;6(5):751-63 [PMID: 18847410]
  249. Nat Commun. 2024 Mar 27;15(1):2702 [PMID: 38538613]
  250. Antimicrob Resist Infect Control. 2019 Oct 21;8:158 [PMID: 31649815]
  251. Semin Respir Crit Care Med. 2015 Oct;36(5):673-80 [PMID: 26398534]
  252. Bioessays. 2021 Feb;43(2):e2000163 [PMID: 33410142]
  253. Microorganisms. 2023 Jan 15;11(1): [PMID: 36677513]
  254. mBio. 2022 Oct 26;13(5):e0185122 [PMID: 36154183]
  255. Environ Health Perspect. 2009 Jun;117(6):A244-50 [PMID: 19590668]
  256. Clin Infect Dis. 2017 Aug 01;65(3):371-382 [PMID: 28369247]
  257. Annu Rev Public Health. 2007;28:435-47 [PMID: 17094768]
  258. Trends Microbiol. 2019 Jul;27(7):570-577 [PMID: 30905524]
  259. Antibiotics (Basel). 2023 Aug 14;12(8): [PMID: 37627733]
  260. J Travel Med. 2019 Dec 23;26(8): [PMID: 31115466]
  261. J Vet Pharmacol Ther. 2021 Mar;44(2):201-206 [PMID: 31777967]
  262. Mil Med Res. 2022 Jan 10;9(1):3 [PMID: 35012680]
  263. AIMS Microbiol. 2018 Jun 26;4(3):482-501 [PMID: 31294229]
  264. Int J Mol Sci. 2022 Jun 13;23(12): [PMID: 35743027]
  265. Anaesth Crit Care Pain Med. 2021 Dec;40(6):100970 [PMID: 34728411]
  266. Chem Soc Rev. 2021 Apr 7;50(7):4514-4540 [PMID: 33595031]
  267. Microorganisms. 2023 Oct 20;11(10): [PMID: 37894253]
  268. Pathogens. 2023 Jan 14;12(1): [PMID: 36678492]
  269. Int J Mol Sci. 2021 Jan 05;22(1): [PMID: 33466437]
  270. Infect Control Hosp Epidemiol. 2023 Mar;44(3):355-376 [PMID: 36751708]
  271. Int J Mol Sci. 2020 Feb 05;21(3): [PMID: 32033477]
  272. Bull World Health Organ. 2018 Feb 01;96(2):101-109 [PMID: 29403113]
  273. Expert Rev Anti Infect Ther. 2023 Jul-Dec;21(10):1025-1055 [PMID: 37740561]
  274. Healthcare (Basel). 2023 Feb 02;11(3): [PMID: 36767000]
  275. Front Microbiol. 2016 Feb 02;6:1536 [PMID: 26869998]
  276. AIDS Res Ther. 2021 Nov 16;18(1):85 [PMID: 34784918]
  277. J Glob Health. 2020 Dec;10(2):020414 [PMID: 33110576]
  278. Curr Med Chem. 2023;30(7):783-808 [PMID: 35726414]
  279. PLoS Pathog. 2019 Aug 8;15(8):e1007878 [PMID: 31393945]
  280. Nature. 2018 Oct;562(7726):192 [PMID: 30305753]
  281. Front Cell Infect Microbiol. 2021 Mar 19;11:618994 [PMID: 33816332]
  282. Lancet. 2016 Jan 9;387(10014):176-87 [PMID: 26603922]
  283. Annu Rev Public Health. 2008;29:151-69 [PMID: 18348709]
  284. Am J Med. 2006 Jun;119(6 Suppl 1):S3-10; discussion S62-70 [PMID: 16735149]
  285. Vaccine. 2019 Jun 19;37(28):3646-3653 [PMID: 31130258]
  286. Curr Top Microbiol Immunol. 2016;398:3-33 [PMID: 27406189]
  287. Clin Microbiol Infect. 2019 Jun;25(6):739-746 [PMID: 30315958]
  288. Toxics. 2023 Feb 16;11(2): [PMID: 36851059]
  289. Heliyon. 2018 Dec 28;4(12):e01067 [PMID: 30619958]
  290. Front Immunol. 2020 Apr 30;11:767 [PMID: 32425944]
  291. Antimicrob Resist Infect Control. 2020 Nov 7;9(1):181 [PMID: 33160396]
  292. Environ Microbiol. 2022 Aug;24(8):3290-3306 [PMID: 35172395]
  293. BMJ Glob Health. 2022 May;7(5): [PMID: 35613837]
  294. Int J Antimicrob Agents. 2020 Jul;56(1):106019 [PMID: 32422315]
  295. Environ Pollut. 2022 Aug 15;307:119603 [PMID: 35691443]
  296. Nat Rev Microbiol. 2021 May;19(5):287-302 [PMID: 33542518]
  297. Ann N Y Acad Sci. 2015 Apr;1342:10-8 [PMID: 25694157]
  298. Health Policy Plan. 2020 Oct 1;35(8):973-982 [PMID: 32743655]
  299. Antibiotics (Basel). 2022 Apr 10;11(4): [PMID: 35453254]
  300. Antimicrob Resist Infect Control. 2023 Sep 7;12(1):94 [PMID: 37679758]
  301. EMBO Rep. 2020 Dec 3;21(12):e51034 [PMID: 33400359]
  302. FEMS Microbiol Rev. 2017 May 1;41(3):430-449 [PMID: 28419231]
  303. BMC Genomics. 2020 Mar 5;21(Suppl 1):106 [PMID: 32138652]
  304. MedComm (2020). 2023 Nov 04;4(6):e420 [PMID: 37929014]
  305. Global Health. 2018 Nov 1;14(1):102 [PMID: 30382856]
  306. Open Forum Infect Dis. 2019 Mar 15;6(Suppl 1):S54-S62 [PMID: 30895215]
  307. Antimicrob Resist Infect Control. 2024 Apr 26;13(1):47 [PMID: 38664757]
  308. Sci Transl Med. 2014 May 14;6(236):236ed10 [PMID: 24828073]
  309. Sci Transl Med. 2021 Aug 11;13(606): [PMID: 34380772]
  310. Curr Opin Microbiol. 2021 Dec;64:91-99 [PMID: 34655936]
  311. Hum Vaccin Immunother. 2023 Aug 1;19(2):2228669 [PMID: 37449650]
  312. Appl Health Econ Health Policy. 2019 Jun;17(3):381-389 [PMID: 30506456]
  313. Fam Pract. 2022 Jan 19;39(1):1-5 [PMID: 34173645]
  314. J Infect Prev. 2022 Jul;23(4):167-185 [PMID: 37256160]
  315. Curr Opin Infect Dis. 2015 Aug;28(4):375-83 [PMID: 26098505]
  316. Infect Drug Resist. 2021 Dec 15;14:5403-5410 [PMID: 34938088]
  317. Antibiotics (Basel). 2021 Jan 19;10(1): [PMID: 33477994]
  318. Environ Pollut. 2017 Apr;223:161-169 [PMID: 28131482]
  319. Front Immunol. 2020 Jun 12;11:1209 [PMID: 32595649]
  320. FEMS Microbes. 2020 Oct 17;1(1):xtaa004 [PMID: 37333955]
  321. J Glob Antimicrob Resist. 2021 Dec;27:101-111 [PMID: 34454098]
  322. PLoS Comput Biol. 2020 Apr 10;16(4):e1007798 [PMID: 32275712]
  323. Am J Infect Control. 2016 Dec 1;44(12):1454-1457 [PMID: 27592161]
  324. JAMA. 2016 Sep 20;316(11):1193-1204 [PMID: 27654605]
  325. Clin Infect Dis. 2018 Mar 5;66(6):963-969 [PMID: 29346620]
  326. Clin Microbiol Rev. 2020 Jun 10;33(3): [PMID: 32522747]
  327. J Hazard Mater. 2019 May 5;369:9-16 [PMID: 30753956]
  328. J Environ Qual. 2016 Mar;45(2):377-93 [PMID: 27065385]
  329. Clin Ther. 2020 Sep;42(9):1649-1658 [PMID: 32819723]
  330. Front Vet Sci. 2021 Mar 24;8:611931 [PMID: 33842569]
  331. Infect Drug Resist. 2020 Dec 29;13:4713-4738 [PMID: 33402841]
  332. Clin Infect Dis. 2017 Aug 15;65(4):644-652 [PMID: 28472416]
  333. J Pharm Policy Pract. 2021 Feb 28;14(1):27 [PMID: 33648589]
  334. Antibiotics (Basel). 2021 May 27;10(6): [PMID: 34071771]
  335. J Antimicrob Chemother. 2022 Feb 23;77(3):556-567 [PMID: 34894259]
  336. J Infect Prev. 2019 Jul;20(4):164-170 [PMID: 31428196]
  337. Environ Microbiol. 2020 Jul;22(7):2457-2460 [PMID: 32363801]
  338. Mycopathologia. 2020 Apr;185(2):279-288 [PMID: 31894500]
  339. Microlife. 2022 Sep 14;3:uqac019 [PMID: 37223353]
  340. Health Aff (Millwood). 2014 Sep;33(9):1620-6 [PMID: 25201667]
  341. Antibiotics (Basel). 2023 Oct 21;12(10): [PMID: 37887258]
  342. Curr Opin Microbiol. 2015 Oct;27:103-7 [PMID: 26356257]
  343. J Biol Chem. 2020 Jul 24;295(30):10340-10367 [PMID: 32499369]
  344. JAC Antimicrob Resist. 2021 Feb 24;3(1):dlab015 [PMID: 34223092]
  345. Am J Infect Control. 2020 Oct;48(10):1204-1210 [PMID: 32178856]
  346. Front Microbiol. 2015 Jul 23;6:758 [PMID: 26257725]
  347. Mol Microbiol. 2000 Jul;37(2):219-25 [PMID: 10931319]
  348. Pediatrics. 2017 Apr;139(4): [PMID: 28270547]
  349. Front Microbiol. 2024 Apr 29;15:1403168 [PMID: 38741745]
  350. JAC Antimicrob Resist. 2023 Feb 17;5(1):dlad018 [PMID: 36816746]
  351. Health Aff (Millwood). 2018 Apr;37(4):662-669 [PMID: 29561692]
  352. AIMS Microbiol. 2020 Jul 22;6(3):204-230 [PMID: 33134741]
  353. Plasmid. 2017 May;91:82-89 [PMID: 28438469]
  354. Infect Dis Clin North Am. 2020 Dec;34(4):649-658 [PMID: 33011053]
  355. Biochem Biophys Res Commun. 2014 Oct 17;453(2):254-67 [PMID: 24878531]
  356. Bioessays. 2021 Aug;43(8):e2100043 [PMID: 34160842]
  357. Semin Respir Crit Care Med. 2015 Feb;36(1):1-2 [PMID: 25643266]
  358. Euro Surveill. 2023 Jun;28(22): [PMID: 37261729]
  359. Infect Drug Resist. 2018 Oct 11;11:1751-1756 [PMID: 30349332]
  360. J Hosp Infect. 2024 Oct;152:36-41 [PMID: 38969207]
  361. Antibiotics (Basel). 2022 Aug 09;11(8): [PMID: 36009948]
  362. Front Vet Sci. 2017 Sep 15;4:148 [PMID: 28966925]
  363. Microorganisms. 2017 Mar 14;5(1): [PMID: 28335438]
  364. Travel Med Infect Dis. 2021 May-Jun;41:102045 [PMID: 33798743]
  365. Crit Care Med. 2020 Jul;48(7):939-945 [PMID: 32282351]
  366. ACS Infect Dis. 2018 Sep 14;4(9):1275-1277 [PMID: 30070470]
  367. Science. 2019 May 24;364(6442):737-738 [PMID: 31123125]
  368. J Travel Med. 2021 Jan 6;28(1): [PMID: 33159509]
  369. Trends Pharmacol Sci. 2014 Feb;35(2):86-102 [PMID: 24439476]
  370. Antimicrob Resist Infect Control. 2022 Jun 23;11(1):90 [PMID: 35739564]
  371. Curr Opin Infect Dis. 2021 Oct 1;34(5):432-439 [PMID: 34267045]
  372. mBio. 2020 Mar 3;11(2): [PMID: 32127449]
  373. PLoS Pathog. 2015 Mar 26;11(3):e1004678 [PMID: 25811381]
  374. Viruses. 2023 Apr 21;15(4): [PMID: 37113000]
  375. BMJ Glob Health. 2022 Jan;7(1): [PMID: 34983786]
  376. Philos Trans R Soc Lond B Biol Sci. 2015 Jun 5;370(1670):20140080 [PMID: 25918439]
  377. Am J Infect Control. 2023 Nov;51(11S):A13-A21 [PMID: 37890943]
  378. Int J Environ Res Public Health. 2018 Dec 23;16(1): [PMID: 30583571]
  379. Acta Naturae. 2018 Oct-Dec;10(4):33-48 [PMID: 30713760]
  380. Cold Spring Harb Perspect Med. 2016 Aug 01;6(8): [PMID: 27329032]
  381. Eur J Investig Health Psychol Educ. 2021 Jan 19;11(1):71-82 [PMID: 34542450]
  382. Infect Drug Resist. 2015 Apr 01;8:49-61 [PMID: 25878509]
  383. Mol Syst Biol. 2023 Mar 9;19(3):e11406 [PMID: 36714980]
  384. Antibiotics (Basel). 2020 Aug 07;9(8): [PMID: 32784768]
  385. BMJ Open. 2020 Mar 31;10(3):e030823 [PMID: 32234736]
  386. Front Microbiol. 2020 Oct 16;11:582779 [PMID: 33178164]
  387. Drug Discov Today. 2019 Jan;24(1):206-216 [PMID: 30036574]
  388. Vet World. 2022 Mar;15(3):743-749 [PMID: 35497962]
  389. Antibiotics (Basel). 2022 Apr 13;11(4): [PMID: 35453271]
  390. Antibiotics (Basel). 2020 Dec 23;10(1): [PMID: 33374551]
  391. Research (Wash D C). 2020 Sep 28;2020:2016201 [PMID: 33083786]
  392. Biochem Pharmacol. 2017 Jun 1;133:117-138 [PMID: 27663838]
  393. NPJ Antimicrob Resist. 2023;1(1):5 [PMID: 38686214]
  394. Sci Rep. 2024 Jan 22;14(1):1895 [PMID: 38253607]
  395. Antimicrob Resist Infect Control. 2019 Jan 29;8:22 [PMID: 30728954]
  396. Infect Drug Resist. 2019 Dec 20;12:3903-3910 [PMID: 31908502]
  397. Antibiotics (Basel). 2020 Jul 16;9(7): [PMID: 32708627]
  398. Trop Med Health. 2023 Jun 7;51(1):33 [PMID: 37287083]
  399. Nanomaterials (Basel). 2020 Mar 20;10(3): [PMID: 32244858]
  400. Health Policy Plan. 2021 Jun 3;36(5):594-605 [PMID: 33822953]

Grants

  1. UIDP/04378/2020, UIDB/04378/2020, LA/P/0140/2020, UIDB/50006/Fundação para a Ciência e Tecnologia

Word Cloud

Created with Highcharts 10.0.0AMRantimicrobialemechanismsstrategiesAntimicrobialresistancehealthcomprehensiveemergencelandscapenewchallengesunderlyingimitigationgantibioticstewardshipuseOneHealthapproachnoveltherapeuticsinterventionspromoteaddresscomplexfrequentlyconsideredmajorglobalpublicthreatrequiresunderstandingadvancesimplicationsAMR'sepidemiologicalcharacterizedwidespreadprevalenceconstantlyevolvingpatternsmultidrug-resistantorganismsMDROscreatingeverydaycommongeneticmutationshorizontalgenetransferselectivepressurecontributedisseminationresistantstrainsThereforeprograms-ASPs-andinfectionpreventioncontrolstrategies-IPCsemphasizeimportanceresponsiblesurveillanceinterconnectednesshumananimalenvironmentalhighlightsnecessityinterdisciplinarycollaborationholisticcombatingAdvancementsalternativeagentsvaccinesofferpromisingavenuesaddressingPolicyinternationalnationallevelsalsoASPsaimingregulateDespiteobservedprogressremainspressingconcerndemandingsustainedeffortsemergingthreatssustainabilityFutureresearchmustprioritizeinnovativeapproachessocioecologicaldynamicsmanuscriptresourceresearcherspolicymakershealthcareprofessionalsseekingnavigatedevelopeffectiveOverviewRecentAdvancesResistanceprogramsepidemiologypolicy

Similar Articles

Cited By